Variable | Cohort 2 | Cohort 3 | ||||||
---|---|---|---|---|---|---|---|---|
N | CUBN negative N (%) | CUBN positive N (%) | P-value | N | CUBN negative N (%) | CUBN positive N (%) | P-value | |
Spread at diagnosis | 131 | 114 | ||||||
Local | 50 (96) | 72 (91) | 15 (33) | 39 (57) | ||||
Metastatic | 2 (4) | 7 (9) | 0.317b | 31 (67) | 29 (43) | 0.009a | ||
T-Stage | 123 | |||||||
T1-T2 | 5 (10) | 14 (19) | n.a. | |||||
T3-T4 | 45 (90) | 59 (81) | 0.167a | |||||
Fuhrman Grade | 95 | |||||||
1–2 | 8 (23) | 31 (52) | n.a. | |||||
3–4 | 27 (77) | 29 (48) | 0.006a | |||||
Nodal Status | 131 | |||||||
Negative | 39 (75) | 73 (92) | n.a. | |||||
Positive | 13 (25) | 6 (8) | 0.006a |